Aggarwal Gaurav

CIK 00015519655 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001551965

Recent Transactions

38 trades

Conversion
Unicycive Therapeutics, Inc.$UNCY
Common Stock
2025-08-25+652,900→ 1,789,915 total
Disposition to Issuer
Unicycive Therapeutics, Inc.$UNCY
Series A-2 Prime Preferred Stock
2025-08-25$1000.00/sh−3,199.21→ 0 total
Award
Unicycive Therapeutics, Inc.$UNCY
Stock Options
2025-07-28+21,200→ 39,200 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2025-05-21+180,000→ 180,000 total
Disposition to Issuer
Unicycive Therapeutics, Inc.$UNCY
Series A-2 Prime Preferred Stock
2025-02-18$1000.00/sh−686→ 3,119.21 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Common Stock
2025-02-18+1,400,000→ 11,370,152 total
Disposition to Issuer
Unicycive Therapeutics, Inc.$UNCY
Series A-2 Prime Preferred Stock
2024-10-09$1000.00/sh−2,695→ 3,885.21 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Common Stock
2024-10-09+5,500,000→ 9,970,152 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2024-05-09+180,000→ 180,000 total
Award
GERON CORP$GERN
Common Stock
2023-12-29+1,970→ 1,970 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2023-11-26+200,000→ 200,000 total
Award
Unicycive Therapeutics, Inc.$UNCY
Stock Options
2023-09-05+180,000→ 180,000 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Series A-1 Preferred Stock
2023-07-11$1000.00/sh−8,077→ 0 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Tranche A Warrants (right to buy)
2023-07-11+12,802,388→ 12,802,388 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Common Stock
2023-07-11+3,470,152→ 3,470,152 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Series A-2 Preferred Stock
2023-07-11+13,429,000→ 13,429,000 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Tranche B Warrants (right to buy)
2023-07-11+11,638,534→ 11,638,534 total
Conversion
Unicycive Therapeutics, Inc.$UNCY
Tranche C Warrants (right to buy)
2023-07-11+18,621,655→ 18,621,655 total
Award
Unicycive Therapeutics, Inc.$UNCY
Series A-1 Convertible Preferred Stock
2023-03-08$1000.00/sh+8,077→ 8,077 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−6,874→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Series A Warrant
2022-07-01−1,455,384→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Common Stock
2022-07-01$55.00/sh−2,735,853→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−1,500→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−6,000→ 0 total
Purchase
Sierra Oncology, Inc.
Common Stock
2022-01-31$27.00/sh+800,000→ 2,735,853 total
Exercise of In-Money
Sierra Oncology, Inc.
Series B Warrant (Right to Purchase)
2022-01-26$13.20/sh−1,455,384→ 0 total
Exercise of In-Money
Sierra Oncology, Inc.
Common Stock
2022-01-26$13.20/sh+480,277→ 1,935,853 total
Award
Sierra Oncology, Inc.
Stock Option (Right To Buy)
2021-06-08+6,000→ 6,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2020-06-09+6,874→ 6,874 total
Conversion
Sierra Oncology, Inc.
Series A Convertible Voting Preferred Stock
2020-01-29−19,213→ 0 total
Conversion
Sierra Oncology, Inc.
Common Stock
2020-01-29+1,455,576→ 1,455,576 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2019-11-29+60,000→ 60,000 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2016-01-15$2.15/sh+10,000→ 20,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-06+147,975→ 147,975 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-06+49,325→ 49,325 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2015-06-18+75,000→ 75,000 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2015-05-06$3.62/sh+7,500→ 10,000 total
Purchase
HYPERION THERAPEUTICS INC
Common Stock
2012-07-31$10.00/sh+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov